The ability of COVID-19 tests to detect emerging genetic variants of SARS-CoV-2
Information
Type
Page
Regulated products
Medical Devices
Topics
COVID-19, In Vitro Diagnostic Medical Devices (IVDs)
Published
June 6, 2023
Last updated
June 6, 2023
Description
Information on the TGA post-market review of all point-of-care and laboratory tests included in the ARTG that are intended to identify patients with COVID-19 to ensure they can detect the emerging SARS-CoV-2 genetic variants and remain accurate.
Tags
Organization
Country / Region
Australia
License
Other (Non-Commercial)